Analyzing Lexaria Bioscience (OTCMKTS:LXRP) and Blue Gold (NASDAQ:BGL)

Blue Gold (NASDAQ:BGL) and Lexaria Bioscience (OTCMKTS:LXRP) are both small-cap basic materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings for Blue Gold and Lexaria Bioscience, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Blue Gold	1	0	0	0	1.00
Lexaria Bioscience	0	0	0	0	0.00

Given Lexaria Bioscience’s higher possible upside, analysts clearly believe Lexaria Bioscience is more favorable than Blue Gold.

Insider and Institutional Ownership

24.6% of Blue Gold shares are owned by institutional investors. Comparatively, 0.1% of Lexaria Bioscience shares are owned by institutional investors. 19.9% of Blue Gold shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Blue Gold and Lexaria Bioscience’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Blue Gold	N/A	N/A	N/A
Lexaria Bioscience	-1,046.77%	-157.62%	-148.09%

Earnings and Valuation

This table compares Blue Gold and Lexaria Bioscience”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Blue Gold	N/A	N/A	$700,000.00	N/A	N/A
Lexaria Bioscience	$380,000.00	0.00	-$4.09 million	N/A	N/A

Blue Gold has higher earnings, but lower revenue than Lexaria Bioscience.

Summary

Blue Gold beats Lexaria Bioscience on 7 of the 9 factors compared between the two stocks.

About Blue Gold

Blue Gold Limited is a gold mining company developing a portfolio of assets anchored by the historic Bogoso Prestea Mine in the Ashanti region of Ghana. Blue Gold Limited, formerly known as Perception Capital Corp. IV, is based in NEW YORK.

About Lexaria Bioscience

Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada.